Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | LSS | P48449 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CCR2 | P41597 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17147739 | 1.00 | CYP1A2 (0.42) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL9154040 | 0.92 | CYP1A2 (0.45) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL22166115 | 0.92 | CYP1A2 (0.45) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL22457914 | 0.92 | CYP1A2 (0.45) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL9154047 | 0.92 | CYP1A2 (0.45) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL19304387 | 0.88 | CYP1A2 (0.54) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL9151281 | 0.87 | ALDH1A1 (0.36) | CYP1A2PKMHTTMEN1KMT2A | |
| SCHEMBL9151284 | 0.87 | ALDH1A1 (0.36) | CYP1A2PKMHTTMEN1KMT2A | |
| SCHEMBL9151287 | 0.87 | ALDH1A1 (0.36) | CYP1A2PKMHTTMEN1KMT2A | |
| SCHEMBL6058639 | 0.86 | TLR4 (0.36) | CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170166816-A1 | PHOTOREACTIVE LIQUID CRYSTAL COMPOSITION, DISPLAY ELEMENT, OPTICAL ELEMENT, METHOD FOR MANUFACTURING DISPLAY ELEMENT, AND METHOD FOR MANUFACTURING OPTICAL ELEMENT | UNIVERSITY OF HYOGO (JP) | 2017-06-15 | — | — | US | disclosed |
| US-7615262-B2 | Liquid crystal material, method for producing liquid crystal material and liquid crystal device | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-11-10 | — | — | US | disclosed |
| US-7615262-B2 | Liquid crystal material, method for producing liquid crystal material and liquid crystal device | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-11-10 | — | — | US | disclosed |
| US-20080266512-A1 | Liquid Crystal Material, Method for Producing Liquid Crystal Material and Liquid Crystal Device | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080266512-A1 | Liquid Crystal Material, Method for Producing Liquid Crystal Material and Liquid Crystal Device | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080266512-A1 | Liquid Crystal Material, Method for Producing Liquid Crystal Material and Liquid Crystal Device | XDH, NLK, OR10J3 | CYP1A2 1810/4885PKM 2902/4885HTT 4801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.